Bio
Kyle Lefkoff, 51, is a Founder and General Partner of Boulder Ventures Ltd. In his twenty-five year career as a venture capitalist, Mr. Lefkoff has invested in sixty Colorado companies, resulting in twelve IPOs and fifteen trade sales. Mr. Lefkoff's representative life science investments include Hauser Chemical Research (NASDAQ: HAUS), NeXstar Pharmaceuticals (sold to Gilead Sciences), Array BioPharma (NASDAQ: ARRY), Dharmacon (sold to Fisher Scientific), Genomica (sold to Exelixis), ARCA biopharma (NASDAQ: ABIO), and Miragen Therapeutics. Representative information technology investments include McData (sold to EMC), Atlantes (sold to Metromail), Compatible Systems (sold to Cisco Systems), Wall Street on Demand (sold to Goldman Sachs), Lefthand Networks (sold to Hewlett Packard), and Market Force Information. Representative natural foods retailing investments include Horizon Organic Dairy (sold to Dean Foods), Alfalfa's Markets (sold to Wild Oats), and Fresh & Wild PLC (sold to Whole Foods). Mr. Lefkoff also serves on the board of Trust Company of America and University License Equity Holding, Inc (ULEHI) at the University of Colorado. He is the past Chairman of the Venture Capital Association of Colorado and is an Adjunct Professor of Finance at the University of Colorado Leeds School of Business.
Career
|
Boulder Ventures LtdEmail: [email protected] |